1. Introduction {#s0005}
===============

Marek\'s disease is an infectious poultry disease caused by cell associated alphaherpesvirus, Marek\'s disease virus (MDV) ([@bb0010]). MDV belongs to subfamily *Alphaherpesvirinae*, genus *Mardivirus* and species: *Gallid herpesvirus 2*, *Gallid herpesvirus 3* and *Meleagrid herpesvirus 1* as reported in ICTV ([@bb0030]). These species of MDV group are classified under three serotypes - 1, 2 and 3 -- on the basis of their pathogenicity and virulence ([@bb0075]). Marek\'s disease virus serotype 1 (MDV1) is categorized as virulent strain where as serotype 2 (MDV2) and serotype 3, herpesvirus of turkeys (HVT) are mild and vaccinal strains, respectively ([@bb0050], [@bb0065]). The disease is associated with several distinct pathological syndromes, of which the lymphoproliferative syndromes are the most frequent and are of most practical significance ([@bb0055]). The disease can occur at 3--4 weeks of age or later but is most common between 12 and 30 weeks of age ([@bb0075]). Although clinical disease is not always apparent in infected flocks, till chickens become persistently infected with MD virus (MDV) resulting in the decreased growth rate and egg production ([@bb0040]). Tentative diagnosis is made based on the neurological symptoms like partial or complete paralysis of the legs and wings, skin leukosis, depression and death. Lymphoid lymphomas, gross or microscopic lesions are associated with atrophy of organs such as thymus, bursa and spleen which is further continued by virus isolation, demonstration of viral antigen or antibodies and detection of the viral nucleic acid ([@bb0020]).

The incidence of MD is quite variable in commercial flocks and depends on various parameters like strain and dose of virus, age at exposure, maternal antibody, host gender and genetics, other concurrent diseases, and several environmental factors including stress. In India reports of MD outbreaks from Orissa, Punjab, Assam, Uttar Pradesh, Andhra Pradesh, Arunachal Pradesh and Tripura, Gujarat appeared periodically and the annual loss accounts for Rs. 4 crores ([@bb0105]). Marek\'s disease (MD) incidence induced by Indian MDV strains was found to be 57.5% and 25% in monovalent and bivalent vaccine inoculated birds, respectively compared to uninoculated control (100%) in a protection test ([@bb0110]).

MD may be prevented by vaccination in ovo or at hatch with monovalent or multivalent live virus vaccines of various types ([@bb0120]). Vaccination does not prevent the birds from infection with the field MDV and their transmission. However, it does reduce the amount of virus shed in dander, hence reduces the horizontal spread of the disease and thus reduce the economic losses. The field isolates of MDV-1 have tended to increase in virulence and cause MD even in vaccinated chickens ([@bb0130]). The number of MD cases has increased in vaccinated chickens during the last few years due to adenovirus infections, which commonly exist in poultry flocks, can be one of the reasons for vaccination failure ([@bb0070]). Thus, MD still remains a serious problem in individual flocks or in selected geographic areas despite of proper vaccination ([@bb0090]). Distinct polymorphism and point mutations in *Meq* gene have been reported to correlate with MDV virulence and oncogenicity ([@bb0090], [@bb0130], [@bb0135], [@bb0045]). Among different genes of virus, the main MDV encoded *Meq* gene which bears resemblance to Jun/Fos family of transcriptional activators is found to have oncogenic expression and is responsible for transformation of T-lymphocyte ([@bb0060]). The *Meq* gene is mainly found in serotype-1 strains of MDV in long and short forms ([@bb0100]) and is related to virulence ([@bb0090]). Live attenuated herpesvirus of turkey (HVT) vaccine based on attenuated FC 126 (HVT) vaccine strain, deficient of various monogenic genes, one of them is Meq gene ([@bb0005]). [@bb0080] showed that the number of repeat sequences of four prolines (PPPP repeats) in the *Meq* gene (overall range 2 to 8) was strongly associated with virulence across all the isolates they studied, with the most pathogenic isolates having the fewest number of repeats. Therefore, the present study was carried out with the objective to isolate and characterize field isolates of Marek\'s disease virus on the basis of *Meq* gene.

2. Materials and methods {#s0010}
========================

2.1. Sample collection {#s0015}
----------------------

Liver and spleen samples (25 each) from vaccinated White Leg Horn (WLH) and Rhode Island Red (RIR) broilers of different age groups, were collected in sterile containers having 50% phosphate buffered glycerin (standard buffer used for collection of samples for virus isolation) from five different flocks of a single poultry farm (See [Table 1](#t0005){ref-type="table"}). All the birds were vaccinated at day one with the live MD-FC 126 vaccine (Hester Biosciences Ltd.) having cell associated HVT strain FC 126. These broilers without any specific clinical symptoms suspected to have died of Marek\'s disease (MD)/lymphoid leukosis (LL) were brought for postmortem to the Department of Veterinary Pathology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab, India during the year 2012. The poultry farm had a previous history of nearly 0.5--1.0% annual mortality due to Marek\'s disease, confirmed by postmortem analysis, although the live birds did not show any MDV specific clinical symptoms.

2.2. Sample processing {#s0020}
----------------------

Liver and spleen samples were washed twice in sterile PBS, cut into small pieces, triturated in the sterile pestle and mortar using sterilized sand and then mixed with phosphate buffered saline (PBS) for preparing a 10% tissue suspension from each sample. The tissue suspensions were transferred into 15 ml tubes and centrifuged at 3000 ×* g* for 10 min at 4 °C. The supernatant was aspirated into new tubes and after addition of 2--3 drops of antibiotic (antibiotic antimycotic solution 100 × liquid endotoxin tested, HIMEDIA) it was incubated at 37 °C for 35--45 min. The inoculums were then used for infecting the duck embryo fibroblast (DEF) cell monolayers or stored at − 80 °C for future use. The second fractions were stored in liquid nitrogen for back up.

2.3. Isolation of MDV in DEF cells {#s0025}
----------------------------------

Primary culture of duck embryo fibroblast (DEF) cells was prepared from 11-day old duck embryos, grown in 6 well cell culture plates using MEM supplemented with 10% fetal bovine serum (FBS, Gibco) and antibiotic antimycotic solution (100 × liquid endotoxin tested, HIMEDIA; having penicillin 100 units/ml, streptomycin 0.10 μg/ml and amphotericin B 0.25 μg/ml of medium) and incubated at 37 °C in presence of 5% CO~2~. Complete DEF monolayers were observed within 24--48 h of culture which were then infected with the inoculums prepared from the field samples keeping one uninoculated well as cell control per plate. Around 500 μl inoculum and 300 μl maintenance medium (MM) were added to each well of a 6 well plate following removal of the growth medium and the plates were incubated at 37 °C for 60 to 90 min for virus adsorption. Then the infected monolayers were washed twice with MM, added 2 ml of MM per well and the plates were incubated for 12 to 15 days for observing visible cytopathic effects (CPE) during which MM was changed at 3 days interval for 2--3 times. Irrespective of the CPE observed, the infected cultures were harvested 12--15 days post inoculation, subjected to 3 cycles of trypsinization and then stored in liquid nitrogen. All the 25 samples (DEF passaged) were given three subsequent passages in the DEF monolayers.

2.4. Detection of MDV by polymerase chain reaction {#s0030}
--------------------------------------------------

Genomic DNA was extracted from all 25 DEF passaged Marek\'s disease (MD)/lymphoid leukosis (LL) suspected samples by using standard laboratory protocol ([@bb0085]). The published primer sequences M1 (forward) 5′-TACTTCCTATATAGATTGAGACGT-3′ and M2 (reverse) 5′-GAGATCCTCGTA AGGTGTAATATA-3′ were used for diagnosis of MDV in the genomic DNA extracted from the DEF passaged samples ([@bb0025]). The PCR products were analyzed by gel electrophoresis at 100 V for 40 min in 1% agarose gel prepared in 0.5 × TBE having 0.5 μg/ml ethidium bromide and the amplicon size was determined by comparing with the 100 bp Plus DNA Ladder (Fermentas) loaded along with the samples.

2.5. PCR amplification of the complete MDV *Meq* gene {#s0035}
-----------------------------------------------------

New primers sequences Meq-F: 5′-ATCCGCTAGCAGAGATGGCTCAGGAGCC-3′ and Meq-R: 5′-GATCACCCGGGGTCTCCCGTCACC-3′ were designed manually for PCR amplification of the complete *Meq* gene (amplicon size 1040 bp) following analysis of GenBank available MDV *Meq* gene sequences. The genomic DNA samples detected as MDV positive by diagnostic PCR were used as template for PCR amplification of *Meq* gene. The PCR reaction mixture of 50 μl volume was prepared containing 5 μl of 10 × *Pfx* platinum buffer (Invitrogen), 5 μl of 10 × PCR Enhancer, 1.5 μl of 50 mM magnesium sulphate, 1 μl each of Meq-F (20 pmol) and Meq-R (20 pmol) primers, 1 μl of dNTPs mix (10 mM), 0.5 μl of platinum *Pfx* DNA polymerase (hot start, 2.5 U/μl), 5--10 μl of genomic DNA (\~ 1.0 μg) and the rest volume nuclease free water. Cycling conditions standardized for PCR amplification included one cycle of initial denaturation at 94 °C for 6 min followed by 5 step up cycles each of denaturation at 94 °C for 45 s, annealing at 56 °C + 1 °C/cycle for 45 s and extension at 72 °C for 2 min, followed by 30 cycles each of denaturation (94 °C for 45 s), annealing (61 °C for 45 s) and extension (72 °C for 2 min), and a final extension at 72 °C for 10 min.

2.6. Cloning and sequencing of the MDV *Meq* gene {#s0040}
-------------------------------------------------

The PCR amplified MDV *Meq* gene was purified by gel extraction method using Pure Link Quick Gel extraction and PCR Purification Combo Kit (Invitrogen) and then cloned in pJET1.2/blunt vector (Thermo Scientific) according to manufacturer\'s instructions. The selected clones were grown overnight in Luria Bertani (LB) broth in a shaker incubator kept at 37 °C and the plasmids were prepared by alkaline lysis method ([@bb0085]). The presence of *Meq* gene insert and its orientation in the purified recombinant plasmid was confirmed by PCR and restriction enzyme (*Pvu* I, *Bgl* II and *Bsp* HI, Fermentas) analysis as per standard protocol. One of the recombinant plasmids (clones) carrying *Meq* gene from each isolate, confirmed in PCR and RE analysis, was then got sequenced by commercial outsourcing.

2.7. Analysis of the MDV *Meq* gene sequences of the isolates {#s0045}
-------------------------------------------------------------

The obtained *Meq* gene sequences were assembled following online Blast analysis, using DNASTAR (Lasergene 7) Software and manually edited. Sequence data containing obscurities were substantiated by resequencing additional recombinant plasmids. The *Meq* gene nucleotide sequence (1020 bp) and the deduced amino acid sequence (339aa) of seven Ludhiana isolates (LDH 1758, LDH 2003, LDH 2483, LDH 2700, LDH 2929 and LDH 3262) were compared with 23 reference MDVs for their similarity. Among these 23 reference strains, one strain was vaccine strain (CV 1988/Rispens), three from Tamil Nadu (India), ten strains were from USA, six from China, two from Australia and one from Russia. Out of the 23 reference strains 13 strains were well characterized with respect to their virulence and pathotype ([Table 2](#t0010){ref-type="table"}). A phylogenetic tree was constructed based on the *Meq* gene amino acid sequences of the seven Ludhiana isolates and 23 MDV reference strains contained within the GenBank database using the maximum parsimony method of Mega 5.20 software. The topological accuracy of the tree was estimated by 1000 bootstrap re sampling.

3. Results {#s0050}
==========

3.1. Virus isolation {#s0055}
--------------------

Primary culture of duck embryo fibroblasts (DEF) was prepared in 6 well cell culture plate where a confluent monolayer was observed within 24--48 h \[[Fig. 1](#f0005){ref-type="fig"}(a)\]. The viral inoculums prepared from liver and spleen tissues of 25 MD suspected birds when used to infect the confluent monolayer of DEF, the MDV specific clear and distinct cytopathic effects (CPE) were observed in 28.00% (7 out of 25) samples within 9--11 days post inoculation (dpi) on second passage onwards \[[Fig. 1](#f0005){ref-type="fig"}(c)\]. The DEF cells started to detach and degenerate 12--13 days onward which was clearly visible on 15 dpi \[[Fig. 1](#f0005){ref-type="fig"}(d)\]. An early CPE was seen as small rounded cells reflecting light waves \[[Fig. 1](#f0005){ref-type="fig"}(b)\]. Later on these cells formed foci and syncytias that detached from the wall of cell culture flask causing formation of plaques \[[Fig. 1](#f0005){ref-type="fig"}(b), (c) and (d)\].

3.2. PCR detection of MDV and amplification of complete Meq gene {#s0060}
----------------------------------------------------------------

PCR could detect MDV specific product of \~ 434 bp size in 28% (7 out of 25) samples confirming the presence of MDV in the DEF passaged samples ([Fig. 2](#f0010){ref-type="fig"}). The same MDV positive DNA samples were used for PCR amplification of the complete *Meq* gene with the help of newly designed primers and proof reading (platinum Pfx) DNA polymerase (Invitrogen). The PCR could successfully amplify a \~ 1040 bp *Meq* gene product from all the seven Ludhiana isolates (LDH 1758, LDH 2003, LDH 2483, LDH 2700, LDH 2929 and LDH 3262) which were also detected positive in MDV diagnostic PCR ([Fig. 3](#f0015){ref-type="fig"}). PCR amplified *Meq* gene products were purified and cloned into pJET/1.2 blunt vectors. Presence of the *Meq* gene insert in the plasmid was confirmed by PCR and RE digestion. Plasmids were prepared from the positive clones and PCR was again carried out to confirm the presence of *Meq* gene insert in the purified recombinant plasmids where \~ 1040 bp product could be amplified from all the seven samples. Presence of the exact sized insert was further confirmed by RE digestion.

3.3. Sequence analysis of isolates {#s0065}
----------------------------------

The GenBank obtained accession numbers for sequences of Meq gene (LDH 1758, LDH 2003, LDH 2483, LDH 2614, LDH 2700, LDH 2929, LDH 3262) of seven Ludhiana isolates are from KF895029.1--KF895035.1 also given in [Table 2](#t0010){ref-type="table"}. Comparisons of the *Meq* gene nucleotide sequences of Ludhiana MDV isolates revealed a nucleotide similarity of 98.9--99.8% although all the isolates were obtained from a single poultry farm over a period of six months. The highest nucleotide similarity between the LDH 1758 and LDH 2483 was 99.80% where as the lowest of 98.90% was found between LDH 2003 and LDH 2929 MDV isolates. The derived amino acid sequence similarity within the 7 Ludhiana isolates was between 98.20 and 100% where the highest similarity (100%) was found between the LDH 1758 and LDH 2483 and the lowest (98.20%) between the LDH 2003 and LDH 2929.

The sequence analysis of all the seven Ludhiana isolates revealed nucleotide substitution at twenty one and amino acid substitution at ten places for all the isolates as compared with each other.

3.4. MDV Meq gene sequence analysis {#s0070}
-----------------------------------

Comparisons of the *Meq* gene nucleotide sequences of Ludhiana isolates with that of 23 reference strains revealed the nucleotide similarity of Ludhiana isolates with those 23 reference strains between 98.10 and 99.40%. Ludhiana *Meq* sequences had the highest similarity of 99.40% with LSY (LN07I) and LCD (SC07II) strain of China, CVI 988/Rispens vaccine strain and CU-2 strain of USA whereas the lowest similarity was found with the L strain of USA at 98.10% as calculated by the MegaAlign programme of DNASTAR Lasergene using Gonnet 250 algorithm ([Fig. 5](#f0025){ref-type="fig"}).

The derived amino acid Meq sequences of Ludhiana MDV isolates were 339aa long whereas Australian, two USA and one Russian isolates showed 57aa sequence insertion in the Meq protein. The Meq amino acid sequence comparisons of the Ludhiana isolates with that of 23 reference strains revealed a similarity between 95.90 and 98.50% ([Fig. 5](#f0025){ref-type="fig"}). Ludhiana Meq sequences had the highest amino acid similarity with the LCD (SC07II), LHC5 (LN08V), WS03 and LSY2 (LN07I) strains of China and, CVI 988 vaccine and CU-2 strains of USA at 98.50%. The lowest similarity of Ludhiana isolates (LDH 2003) with that of 23 reference MDVs was 95.90% with the TK strain of USA. Also, according to [@bb0115], similarity of Meq gene of China and other countries is 95.0--98.8%.

Meq aa sequence of the six Ludhiana isolates (LDH 1758, LDH 2003, LDH 2483, LDH 2614, LDH 2700, LDH 3262) revealed presence of five repeat sequences of four prolines (PPPP repeats) and one isolate (LDH 2929) showed four repeats indicating their virulence potential.

A phylogenetic tree was constructed based on the *Meq* gene amino acid sequences of the 7 Ludhiana isolates and 23 MDV reference strains which revealed five major clusters ([Fig. 4](#f0020){ref-type="fig"}). All the 7 Ludhiana isolates formed a separate cluster (I) and found to be closely related with the Chinese isolates \[LCD(SC07II), WS03, LSY2(LN07I), LDH(JL07I), LHC4(LN08IV) and LHC5(LN08V)\] along with one USA strain 567 which formed a separate cluster (II) as compared to the other reference strains. The third cluster (III) comprised of Tamil Nadu strains (TN-n1, TN-n2 and Tn-n3), USA mild virulent (CU-2), USA virulent (GA) very virulent (vv) strains (595, Md-5 & RB1B), and three very virulent plus (vv +) strains (L, N & TK). The fourth cluster (IV) comprised of Australian strains (MPF57 and FT158), Russian vaccine strain 3004 and USA strain JM and the fifth cluster (V) is comprised of CVI988/Rispens which represents the amino acid sequence of Meq protein of the named CVI988/Rispens strain was highly divergent. Thus this strain formed a separate branch ([Fig. 4](#f0020){ref-type="fig"}).

4. Discussion {#s0075}
=============

In the past 40 years, the virulence of MDVs has been increasing gradually, possibly caused by the selective pressure of vaccination ([@bb0035], [@bb0125]). Moreover, early infection of the birds with some viruses like chicken infectious anaemia virus, infectious bursal disease virus and fowl adenovirus strains which cause long-lasting immunosuppression can decrease the efficiency of the Marek\'s disease vaccine. Polymorphism, point mutations and the number of repeat sequences of four prolines (PPPP repeats) in the *Meq* gene (overall range 2 to 8) have been reported to correlate with MDV virulence and oncogenicity ([@bb0090], [@bb0080]). In spite of proper vaccination, MD has frequently being reported from different parts of India. In this study, liver and spleen tissue samples from 25 MD/LL suspected birds collected within a period of six months from a single farm when processed for virus isolation in DEF primary culture, 7 samples showed characteristic CPE of MDV in the form of plaques and syncytia. Several workers have successfully isolated Marek\'s disease virus (MDV) serotype 1 in DEF cells from the field samples ([@bb0090], [@bb0135]). Presence of MDV in these 7 samples was confirmed by PCR using specific diagnostic primers and the complete *Meq* oncogene (\~ 1040 bps) was successfully amplified cloned and then sequenced from all the 7 Ludhiana isolates. Many other workers have amplified MDV *Meq* gene with a variable product length of 814--1062 bp ([@bb0015], [@bb0090], [@bb0095], [@bb0130], [@bb0135]).

Compared with 23 reference strains, 7 Ludhiana isolates had the highest *Meq* nucleotide sequence similarity with LSY (LN07I), LCD (SC07II), CVI 988/Rispens vaccine strain and mCU-2 strain at 99.40% whereas the lowest similarity was found with the vv + L strain at 98.10%. Interestingly, the nucleotide similarity among the 7 Ludhiana isolates varied from 98.90--99.80% due to point mutation at various places throughout the gene length. Although, all the seven Ludhiana isolates were obtained from a single poultry farm over a period of six months the *Meq* gene sequence variation might be due to high mutation capability of the MDV field isolates. The reasons of this high mutation rate of MDV may be antibody pressure of the host against the virus because of wide spread vaccination with HVT or it could be repeated exposure of the birds of different age groups and circulation of the virus among various generations in the poultry farm. The other possibility is that these might have occurred during the serial passage of the MDV isolates in DEF primary culture, which is however, less likely.

Several point mutations have been shown in 13 MDV Polish strains which were correlated with the MDV virulence ([@bb0130]). Likewise, distinct polymorphism and point mutations have been shown in the gene encoding C terminal sequences of the Meq protein C terminus of the encoded Meq protein ([@bb0090]).

Furthermore, Meq protein sequence of all the six Ludhiana isolates (LDH 1758, LDH 2003, LDH 2483, LDH 2614, LDH 2700 and LDH 3262) revealed presence of five repeat sequences of four prolines (PPPP repeats) and one isolate (LDH 2929) showed four repeats indicating its virulence potential. It has been established that the number of repeat sequences of four prolines (PPPP repeats) in the *Meq* gene (overall range 2 to 8) was strongly associated with virulence across all isolates, with the most pathogenic isolates having the fewest number of repeats ([@bb0080]).

On phylogenetic analysis, the 7 Ludhiana isolates and 23 MDV reference strains revealed five major clusters. All the Ludhiana isolates formed a separate cluster and found to be closely related with the Chinese isolates along with one USA strain 567 which formed a separate cluster as compared to the other reference strains.

The Meq protein amino acid sequence similarity (95.90--98.50%) of the seven Ludhiana isolates was found to be more than the *Meq* gene nucleotide sequence similarity (98.90--99.80%) ([Fig. 5](#f0025){ref-type="fig"}) which further confirmed the higher mutation rate of the MDV field strains. Similarly, high point mutation rate and higher polymorphism in Meq protein coding sequences have been reported by several workers which was also correlated with the virulence and transformation efficiency of the MDVs ([@bb0045], [@bb0080], [@bb0090], [@bb0125], [@bb0135]).

In conclusion, out of 25 MDV suspected samples virus could be detected and isolated from 7 samples only (28.00%). Meq amino acid sequence variation was found to be more as compared to the nucleotide sequences among the Ludhiana MDV isolates obtained from a single farm. Six MDV field isolates showed 5 repeat sequences of 4 prolines (PPPP) and one isolate showed 4 such repeats indicating their virulence potential. Though, the virulence of a specific isolate of MDV strain is not likely to be exclusively determined only by mutations in a single gene of the virus, the outcome of this research propose that sequencing of the Meq gene and amino acid alignment to determine the number of four proline repeats will provide a useful indication of the probable pathogenicity of the isolate.

Further detailed molecular epidemiological studies of the MDV isolates from different regions are required which will help in choosing a better immunization protocol so as to prevent the MDV infection in field.

Appendix A. Supplementary data {#s0080}
==============================
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![(a) Primary culture of duck embryo fibroblast (DEF) cells, (b) cells started showing CPE of MDV at 7 dpi, (c) CPE at 11 dpi, (d) CPE at 15 dpi.](gr1){#f0005}

![PCR detection of MDV with an amplicon size of \~ 434 bp. Lane 1: positive control, 2: 2233, 3: 2546, 4: 2483, 5: 2929, 6: 3087, 7: 2614, M: 1 kb plus GeneRuler DNA Ladder, Thermo, 8: 2003, 9: 3079, 10: 3989, 11: 15,977, 12: 255, 13: NTC, 14: 4433, 15: 3077, 16: 3088, 17: 708, 18: 1758, 19: 2025, 20: 2700, 21: 3302, 22: 2697, M: 1 kb plus GeneRuler DNA Ladder, Thermo, 23: 3265, 24: 3977, 25: 3992, 27: 2552, 28: 3262.](gr2){#f0010}

![Meq gene amplification of positive samples.](gr3){#f0015}

![The tree shown was generated with Mega 5.0 using Meq protein sequences of different MDV isolates. The tree was generated using maximum parsimony method with 1000 bootstrap value.](gr4){#f0020}

![Sequence distances of deduced amino acid sequences prepared by using Gonnet 250 algorithm of MegaAlign programme of DNASTAR Lasergene software following clustal W analysis.](gr5){#f0025}

###### 

History of MDV samples collected from 5 different flocks of a single farm.

Table 1

  S. no.   Type and age of birds   Lab identification no.   Vaccination    Clinical symptoms
  -------- ----------------------- ------------------------ -------------- -------------------
  1        Broiler 12--18 weeks    2697                     HVT (FC 126)   MD/LL suspected
  2        Broiler 12--18 weeks    2233                     HVT (FC 126)   MD/LL suspected
  3        WLH adult               708                      HVT (FC 126)   MD suspected
  4        RIR adult               1597                     HVT (FC 126)   MD suspected
  5        Broiler 12--18 weeks    1758                     HVT (FC 126)   MD suspected
  6        Broiler 12--18 weeks    2003                     HVT (FC 126)   MD suspected
  7        Broiler adult           2483                     HVT (FC 126)   MD/LL suspected
  8        Broiler adult           2552                     HVT (FC 126)   MD/LL suspected
  9        Broiler 12--18 weeks    2546                     HVT (FC 126)   MD/LL suspected
  10       Broiler 12--18 weeks    3079                     HVT (FC 126)   MD/LL suspected
  11       RIR 1--6 weeks          2025                     HVT (FC 126)   MD suspected
  12       Broiler 12--18 weeks    2547                     HVT (FC 126)   MD/LL suspected
  13       Broiler 12--18 weeks    2614                     HVT (FC 126)   MD suspected
  14       Broiler 18--24 weeks    2700                     HVT (FC 126)   MD/LL suspected
  15       Broiler 18--24 weeks    2929                     HVT (FC 126)   MD suspected
  16       Broiler 12--18 weeks    3262                     HVT (FC 126)   MD suspected
  17       Broiler 12--18 weeks    3077                     HVT (FC 126)   MD suspected
  18       Broiler 12--18 weeks    3087                     HVT (FC 126)   MD suspected
  19       Broiler 12--18 weeks    3088                     HVT (FC 126)   MD/LL suspected
  20       WLH adult               3265                     HVT (FC 126)   MD suspected
  21       Broiler 12--18 weeks    3302                     HVT (FC 126)   MD suspected
  22       Broiler adult           3992                     HVT (FC 126)   MD suspected
  23       BV-300 adult            3977                     HVT (FC 126)   MD/LL suspected
  24       Adult WLH               3989                     HVT (FC 126)   MD/LL suspected
  25       Adult RIR               4433                     HVT (FC 126)   MD/LL suspected

LL -- lymphoid leukosis; MD - Marek\'s disease.

###### 

*Meq* gene from different MDV isolates analyzed.

Table 2

  MDV strain/sample   Number of PPPP repeats   Virulence   Origin               Accession number
  ------------------- ------------------------ ----------- -------------------- ------------------
  LDH 1758            5                        N/A         India (North)        KF895029.1
  LDH 2003            5                        N/A         India (North)        KF895030.1
  LDH 2483            5                        N/A         India (North)        KF895031.1
  LDH 2614            5                        N/A         India (North)        KF895032.1
  LDH 2700            5                        N/A         India (North)        KF895033.1
  LDH 2929            4                        N/A         India (North)        KF895034.1
  LDH 3262            5                        N/A         India (North)        KF895035.1
  tn-n1               5                        N/A         India (South)        HM749324.1
  tn-n2               4                        N/A         India (South)        HM749325.1
  tn-n3               4                        N/A         India (South)        HM749326.1
  FT158               5                        vvMDV       Australia            EF523771.1
  MPF57               5                        vMDV        Australia            EF523774.1
  LCD (SC07II)        4                        N/A         China                HQ658611.1
  LDH (JL07I)         3                        N/A         China                HQ658614.1
  LHC4 (LN08IV)       3                        N/A         China                HQ658618.1
  LHC5 (LN08V)        3                        N/A         China                HQ658619.1
  WSO3                3                        N/A         China                HQ638152.1
  LSY2 (LN071)        3                        N/A         China                HQ658625.1
  L strain            2                        vv + MDV    USA                  AY362717.1
  567 strain          4                        v + MDV     USA                  AY362709.1
  595 strain          2                        vv + MDV    USA                  AY362715.1
  GA strain           5                        vMDV        USA                  M89471.1
  CU-2 strain         7                        mMDV        USA                  AY362708.1
  JM strain           7                        vMDV        USA                  HM488348.1
  Md5 strain          4                        vvMDV       USA                  AF243438.1
  N strain            2                        vv + MDV    USA                  AY362718.1
  RB1B                5                        vvMDV       USA                  AY243332.1
  TK strain           2                        vv + MDV    USA                  AY362721.1
  3004 strain         7                        attMDV      USA                  EU032468.1
  CVI988              4                        attMDV      Commercial vaccine   AF493555.1
